Urology · New York, NY
NPI
1275554933
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
120 E 34th St
New York, NY, 10016
Phone (212) 686-1140
Groups this clinician bills Medicare through
Medicare paid, 2024
$419K
7,912 services
Medicare patients, 2024
585
Average age 75
Drug cost, 2024
$2.5M
3,027 prescriptions
Company payments, 2025
$467
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert W Gluck was code 99212 (office e&m - established), 789 times for 449 patients. In total Robert W Gluck billed 7,912 services in 81 codes, and Medicare paid $419K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 789 | 449 | $41.88 | $33K |
| 51741 Test - Miscellaneous | Office | 424 | 342 | $7.12 | $3,020 |
| 36415 Venipuncture Blood Collection | Office | 417 | 318 | $3.93 | $1,639 |
| 84154 Clinical Chemistry | Office | 414 | 316 | $18.02 | $7,460 |
| 84153 Clinical Chemistry | Office | 414 | 315 | $18.02 | $7,460 |
| 84060 Clinical Chemistry | Office | 411 | 313 | $7.49 | $3,078 |
| 51784 Neurologic | Office | 325 | 308 | $26.36 | $8,568 |
| 51728 Other Organ Systems | Office | 323 | 306 | $286.35 | $92K |
| 99213 Office E&M - Established | Office | 308 | 195 | $70.72 | $22K |
| 83002 Clinical Chemistry | Office | 289 | 266 | $18.12 | $5,236 |
| 84403 Clinical Chemistry | Office | 289 | 266 | $25.26 | $7,302 |
| 84146 Clinical Chemistry | Office | 289 | 266 | $18.99 | $5,488 |
| 83001 Clinical Chemistry | Office | 289 | 266 | $18.17 | $5,252 |
| 84410 Clinical Chemistry | Office | 288 | 265 | $50.16 | $14K |
| 84270 Clinical Chemistry | Office | 286 | 263 | $21.29 | $6,089 |
By year: 2022 $468K for 8,045 services; 2023 $477K for 7,075 services; 2024 $419K for 7,912 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 417 | 318 | $3.93 | $1,639 |
| 84154 Clinical Chemistry | 414 | 316 | $18.02 | $7,460 |
| 84153 Clinical Chemistry | 414 | 315 | $18.02 | $7,460 |
| 84060 Clinical Chemistry | 411 | 313 | $7.49 | $3,078 |
| 83002 Clinical Chemistry | 289 | 266 | $18.12 | $5,236 |
| 83001 Clinical Chemistry | 289 | 266 | $18.17 | $5,252 |
| 84146 Clinical Chemistry | 289 | 266 | $18.99 | $5,488 |
| 84403 Clinical Chemistry | 289 | 266 | $25.26 | $7,302 |
| 84410 Clinical Chemistry | 288 | 265 | $50.16 | $14K |
| 84270 Clinical Chemistry | 286 | 263 | $21.29 | $6,089 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert W Gluck prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,047 prescriptions and refills. In total Robert W Gluck wrote 3,027 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,047 | 2,708 | 396 | $23K |
| Finasteride Generic | 437 | 1,176 | 154 | $4,695 |
| Lupron Depot Leuprolide Acetate | 207 | 1,238 | 155 | $2.3M |
| Ciprofloxacin Hcl Generic | 161 | 161 | 150 | $636 |
| Myrbetriq Mirabegron | 156 | 237 | 37 | $98K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 139 | 356 | 49 | $2,737 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 98 | 98 | 56 | $2,295 |
| Terazosin Hcl Generic | 74 | 204 | 22 | $667 |
| Silodosin Generic | 67 | 134 | 29 | $4,784 |
| Dutasteride Generic | 61 | 180 | 22 | $2,027 |
| Gemtesa Vibegron | 58 | 76 | 20 | $36K |
| Doxazosin Mesylate Generic | 51 | 124 | 11 | $764 |
| Trospium Chloride Generic | 47 | 100 | 19 | $3,094 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 42 | 86 | 13 | $894 |
| Testosterone Generic | 37 | 37 | Under 11 | $7,852 |
Brand drugs: - claims; generic drugs: 2,576 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert W Gluck $467 ($467 in general payments such as food, travel and fees) from 9 companies. The largest payer was Olympus America Inc. with $92.42.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.